As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor ...

MAIA Biotechnology, Inc.’s MAIA share price has dipped by 6.09%, which has investors questioning if this is right time to buy ...

Nautilus Biotechnology, Inc.’s NAUT share price has dipped by 7.04%, which has investors questioning if this is right time to ...

Puma Biotech (PBYI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Radiopharma biotech Cellectar Biosciences is seeking strategic alternatives, opening the door to further opportunities after ...

Iovance Biotherapeutics (NASDAQ: IOVA) and CRISPR Therapeutics (NASDAQ: CRSP) are two incredibly innovative biotechs, but ...

The preclinical results were highlighted at the AACR Annual Meeting in Chicago, Illinois, on April 28, 2025, drawing ...

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

May has just begun, and it's time to turn our attention to the FDA decisions on deck for the coming weeks.So far this year, the U.S. regulatory agency has approved only ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Here is my list of three expert market predictions for May 2025, including insights on yields and job market trends. Read ...

Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech firm reported ...